Patents by Inventor Olivier LE COZ

Olivier LE COZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240132897
    Abstract: The present invention provides a method and a pharmaceutical composition for the treatment of the NDO comprising the viral expression vector carrying a transcription cassette that harbors transgene(s) inhibiting/silencing neurotransmission or synaptic transmission of afferent neurons.
    Type: Application
    Filed: December 11, 2023
    Publication date: April 25, 2024
    Inventors: François GIULIANO, Alberto EPSTEIN, Olivier LE COZ, Alejandro ARANDA
  • Publication number: 20230134548
    Abstract: The present invention provides a method and a pharmaceutical composition for the treatment of the NDO comprising the viral expression vector carrying a transcription cassette that harbors transgene(s) inhibiting/silencing neurotransmission or synaptic transmission of afferent neurons.
    Type: Application
    Filed: July 15, 2022
    Publication date: May 4, 2023
    Applicants: UNIVERSITE DE VERSAILLES-ST QUENTIN EN YVELINES, ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
    Inventors: François GIULIANO, Alberto EPSTEIN, Olivier LE COZ, Alejandro ARANDA
  • Patent number: 11414666
    Abstract: The present invention provides a method and a pharmaceutical composition for the treatment of the NDO comprising the viral expression vector carrying a transcription cassette that harbors transgene(s) inhibiting/silencing neurotransmission or synaptic transmission of afferent neurons.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: August 16, 2022
    Assignees: UNIVERSITE DE VERSAILLES-ST QUENTIN EN YVELINES, ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
    Inventors: François Giuliano, Alberto Epstein, Olivier Le Coz, Alejandro Aranda
  • Publication number: 20200071703
    Abstract: The present invention provides a method and a pharmaceutical composition for the treatment of the NDO comprising the viral expression vector carrying a transcription cassette that harbors transgene(s) inhibiting/silencing neurotransmission or synaptic transmission of afferent neurons.
    Type: Application
    Filed: June 23, 2017
    Publication date: March 5, 2020
    Applicants: UNIVERSITE DE VERSAILLES-ST QUENTIN EN YVELINES, ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
    Inventors: François GIULIANO, Alberto EPSTEIN, Olivier LE COZ, Alejandro ARANDA